These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group. Roman S; Gyawali CP; Savarino E; Yadlapati R; Zerbib F; Wu J; Vela M; Tutuian R; Tatum R; Sifrim D; Keller J; Fox M; Pandolfino JE; Bredenoord AJ; Neurogastroenterol Motil; 2017 Oct; 29(10):1-15. PubMed ID: 28370768 [TBL] [Abstract][Full Text] [Related]
25. Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus. Ribolsi M; Frazzoni M; Marabotto E; De Carlo G; Ziola S; Maniero D; Balestrieri P; Cicala M; Savarino E Aliment Pharmacol Ther; 2021 Aug; 54(4):412-418. PubMed ID: 34181753 [TBL] [Abstract][Full Text] [Related]
26. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux. Roman S; Keefer L; Imam H; Korrapati P; Mogni B; Eident K; Friesen L; Kahrilas PJ; Martinovich Z; Pandolfino JE Neurogastroenterol Motil; 2015 Nov; 27(11):1667-74. PubMed ID: 26337396 [TBL] [Abstract][Full Text] [Related]
27. Is the proton pump inhibitor test helpful in patients with laryngeal symptoms? Kim JH; Sung IK; Hong SN; Lee SY; Park HS; Shim CS Dig Dis Sci; 2013 Jun; 58(6):1663-7. PubMed ID: 23443492 [TBL] [Abstract][Full Text] [Related]
28. Tailored therapy for the refractory GERD patients by combined multichannel intraluminal impedance-pH monitoring. Xiao Y; Liang M; Peng S; Zhang N; Chen M J Gastroenterol Hepatol; 2016 Feb; 31(2):350-4. PubMed ID: 26202002 [TBL] [Abstract][Full Text] [Related]
29. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring. Hirano I Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():12-24. PubMed ID: 16483266 [TBL] [Abstract][Full Text] [Related]
30. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422 [TBL] [Abstract][Full Text] [Related]
31. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease. Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439 [TBL] [Abstract][Full Text] [Related]
36. Prospective validation of reflux monitoring by impedance-pH in predicting PPI response in typical GERD. Ribolsi M; Savarino E; Frazzoni M; Cicala M Dig Liver Dis; 2023 Jun; 55(6):721-726. PubMed ID: 36572569 [TBL] [Abstract][Full Text] [Related]
37. Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms. Triadafilopoulos G; Zikos T; Regalia K; Sonu I; Fernandez-Becker NQ; Nguyen L; Nandwani MCR; Clarke JO Dig Dis Sci; 2018 Oct; 63(10):2673-2680. PubMed ID: 29959725 [TBL] [Abstract][Full Text] [Related]